期刊文献+

保乳治疗对年轻三阴性乳腺癌患者的治疗价值与临床预后分析 被引量:2

下载PDF
导出
摘要 目的研究保乳治疗对年轻三阴性乳腺癌患者的治疗价值与预后效果。方法将2009年1月至2012年1月,我院住院部收治有年轻三阴性乳腺癌患者共40例作为本研究观察对象,另选择同期收治年轻非三阴性乳腺癌患者40例作为对照对象,分别设置为观察组与对照组。两组患者均应用保乳手术治疗。对患者进行为期5年随访,随访调查总生存率、局部复发率、远处转移率以及无病生存率差异。结果观察组总生存率95.00%(38/40)以及局部复发率7.50%(3/40)与对照组对比无显著差异(P>0.05),远处转移率15.00%(6/40)以及无病生存率77.50%(31/40)与对照组对比有显著差异(P<0.05)。结论与非三阴性乳腺癌患者相比,三阴性乳腺癌患者行保乳治疗下局部复发率、生存率无明显差异,提示保乳治疗是三阴性乳腺癌的首选方案,但远处转移风险相对较高,可能影响患者无病生存时间。需进一步展开临床研究以探讨最佳全身治疗方案。
出处 《中国医药指南》 2018年第22期52-53,共2页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献35

  • 1Aksoy S, Dizdar O, Harputluoglu H, et al. Demographic, clinical, and pathological Characteristics of Turkish triple-negative breast cancer pa- tients: single center experience[ J]. Ann 0ncol,2007 , 18 ( 11 ) : 1904-6.
  • 2Rakha EA, E1,Sayed ME, Green AR, et al. Prognostic markers in triple- negative breast cancer[ J ]. Cancer,2007 , 109 ( 1 ) :25-32.
  • 3Carey LA, Dees EC, Sawyer L,et al. The triple negative paradox: primary tumor ehemosensitivity of breast cancer subtypes [ J] Clin Cancer Res, 2007 , 13 (8) :2329-34.
  • 4Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [ J]. Clin Cancer Res,2004 ,10 (16) :5367-74.
  • 5Brown M, Tsodikov A, Bauer KR, et al. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and pro- gesterone receptor-negative ,invasive breast cancer:The California Cancer Registry, 1999-2004 [ J }. Cancer,2008 , 112 (4) :737-47.
  • 6Rodriguez-Pinilla SM, Sarrio D, Honrado E, et al. Prognostic significance of basal-iike phenotype and fascin expression in node negative invasive breast carcinomas [ J ]. Clin Cancer Res,2006 , 12 ( 5 ) : 1533-9.
  • 7Dent R,Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence [ J ]. Clin Cancer Res, 2007 , 13 ( 15 ) :4429-34.
  • 8Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[ J]. Nature, 2000, 406: 747-752.
  • 9CancerDawood S, Lei X, Litton JK, et al. Impact of body mass index on survival outcome among women with early stage triple- negative breast cancer[J]. Clin Breast Cancer, 2012, 12: .364-372.
  • 10Antonio CW, Elizabeth HH, JN. Schwartz, et al. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer[J] Arch Pathol l,ab Med, 2007, 131: 18-43.

共引文献101

同被引文献21

引证文献2

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部